¯

Indian Pharmacopoeia Commission

Aug. 6, 2026

Recently, the Indian Pharmacopoeia Commission (IPC) has been recognised as the World Health Organization South-East Asia Regulatory Network (WHO-SEARN) Regional Centre of Excellence in Pharmacovigilance and the Technical Centre in Quality.

About Indian Pharmacopoeia Commission:

  • It is an autonomous institution of the Ministry of Health and Family Welfare, Government of India.
  • It is created to set standards of drugs in the country.
  • Functions of Indian Pharmacopoeia Commission:
    • Its basic function is to regularly update the standards of drugs commonly required for treatment of diseases prevailing in this region.
    • It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).
    • It further promotes rational use of generic medicines by publishing National Formulary of India.
    • It prescribes standards for identity, purity and strength of drugs essentially required from the health care perspective of human beings and animals.
    • It also provides IP Reference Substances (IPRS) which act as a fingerprint for identification of an article under test and its purity as prescribed in IP.

Key Facts about World Health Organization South-East Asia Regulatory Network

  • It is a collaborative platform established by the World Health Organization (WHO) South-East Asia Regional Office (SEARO) to strengthen regulatory systems across Member States.
  • It was established in 2016.
  • SEARN has facilitated cooperation among National Regulatory Authorities through knowledge sharing, regulatory convergence, capacity building, and reliance mechanisms.
  • The network operates through thematic working groups focusing on key regulatory functions, including quality assurance, pharmacovigilance, clinical trials oversight, regulatory preparedness, and medical device regulation.

Latest Current Affairs

See All

Enquire Now